An international team of scientists committed to reducing the burden of common disease and increasing equity in genomic medicine across ancestries

The Allelica team is dedicated to advancing common disease risk prediction across health systems in the US and around the world.

Advisory Board

photo
Robert Green MD MPH

Professor of Medicine (Genetics) at Harvard Medical School, Director of the G2P Research Program at Brigham and Women's Hospital, Broad Institute and Ariadne Labs

university
Biography

Robert C. Green, MD, MPH is Professor of Medicine (Genetics) at Harvard Medical School and a physician-scientist who directs the G2P Research Program at Brigham and Women’s Hospital, Broad Institute and Ariadne Labs. Dr. Green is internationally recognized for research and policy efforts accelerating the implementation of genomic/precision medicine.

Dr. Green is board certified in both neurology and medical genetics. He is a Board Member of the Council for Responsible Genetics and works within the Global Alliance for Genomics and Health and the All of Us Research Program on designing efforts to return research information, particularly genomic information, to research participants.

Dr. Green led the first experimental trials disclosing common complex disease risk (REVEAL Study) and the first prospective studies of direct-to-consumer genetic testing services (PGen Study). He currently leads and co-leads the first NIH funded randomized trials of sequencing in adults, newborns, and active duty US military personnel.

Dr. Green created the concept of aggregate penetrance of genomic variants in prospective population cohorts.His research is focused on demonstrating the feasibility of genomic sequencing in healthy newborns, paving the way for humans to gain lifelong medical benefits from genomics.

Scroll to read more
photo
Aleksandar Rajkovic MD PhD

Chief Genomics Officer, UCSF Health Center for Clinical Genetics and Genomics

university
Biography

Dr. Rajkovic is the UCSF Chief Genomics Officer, Professor of Pathology,tand the Medical Director and Chief of the Center for Genetic and Genomic Medicine in the UCSF Health System.

Prior to his position at UCSF,he was the Chief of Medical and Laboratory Genetics at the University of Pittsburgh Medical Center where he oversaw Pittsburgh molecular genomic laboratories as well as adult/cancer clinical services.

Dr. Rajkovic is also the Director of the Genomic Medicine Initiative, a translational arm of the Institute of Human Genetics.

He has served as a member and director on numerous NIH study sections and workshops, March of Dimes advisory committee on prematurity and American College of Obstetrics and Gynecology Committee on Genetics.

His research investigates the use of genetics data for large scale implementation and the genetic underpinnings of the formation and differentiation of gametes and reproductive tract, their role of these genes in human disease, embryo lethality and origin of heritable human disorders.

Scroll to read more
photo
Gordon S. Huggins MD

Director, Molecular Cardiology Research Institute, Tufts University School of Medicine

university
Biography

Dr. Huggins is the Director of the Molecular Cardiology Research Institute (MCRI) Center for Translational Pharmacology and Genomics, Associate Professor at Tufts University School of Medicine,and a practicing cardiologist. He led the NHLBI Heart Failure Network program at Tufts and co-directed the Committee onParticipation of Women in Heart Failure Clinical Trials.

Previously, Dr. Huggins spent four years at The Massachusetts General Hospital in theCardiology Division where he completed his clinical training.

In addition to his work in Tufts Medical Center,he is also a faculty member at Tufts Graduate School ofBiomedical Sciences Clinical Translational Sciences Program,Genetics Program and Cell, Molecular and Developmental Biology Program.

His research interest is focused on making scientific discoveries relevant to human diseases that may translate to new biomarkers or therapies.

Scroll to read more
photo
Noura S. Abul-Husn MD PhD

Clinical Director, Institute for Genomic Health, Icahn School of Medicine at Mount Sinai

university
Biography

Dr. Abul-Husn is the founding Chief of the Division of Genomic Medicine in the Department of Medicine, and Clinical Director of the Institute for Genomic Health at the Icahn School of Medicine at Mount Sinai. She is an Associate Professor of Medicine and Genetics and board certified in Internal Medicine and Medical Genetics.

Dr. Abul-Husn is an expert at leveraging large-scale genomic data linked to electronic health records. Her work has been published in leading journals, including Science, Cell, and the New England Journal of Medicine.

She is also a principal investigator in the eMERGE (electronic Medical Records and Genomics) Network.

Dr. Abul-Husn has senior-level pharmaceutical industry experience, having served as director of Translational Genetics at the Regeneron Genetics Center.

Her research is focused on uncovering the clinical impact of human genetic variation in diverse populations and driving the equitable implementation of genomic medicine.

Scroll to read more
photo
Bjarni Jóhann Vilhjálmsson PhD

Professor at Department of Economics and Business Economics, Aarhus University

university
Biography

Dr. Vilhjálmsson is a Professor at the National Centre for Register-based Research and at the Bioinformatics Research Centre at Aarhus University. Vilhjalmsson is a statistical geneticist who is motivated to leverage large population-scale data to understand the interplay between genetic and environmental factors when determining the causes of disease. He currently leads a research group at Aarhus University that is focused on developing methods that integrate electronic health records and large genetic data to understand psychiatric disorders and other diseases.

He is the author of LDpred, one of the most cited methods and software for deriving Polygenic risk Scores (PRS). LDpred contributed significantly to the development of the entire PRS field, having been used in a number of PRS seminal papers that have highlighted the value of PRSs in clinical settings.

Dr. Vilhjálmsson completed his PhD in Computational Biology from the University of Southern California in 2011, and went on to do postdoctoral research at Harvard School of Public Health, Harvard University, and later at the Bioinformatics Research Centre (BiRC) of Aarhus University. In 2016 Dr. Vilhjalmsson left academia to work as a software product owner at QIAGEN, but rejoined academia at Aarhus University to establish his own research group. Dr. Vilhjalmsson was awarded the prestigious Lundbeck Fellow grant in 2020.

Scroll to read more
photo
Alessandro Boccanelli MD

Director of the Italian Society of Geriatric Cardiology, Professor, Uni Camillus

university
Biography

Professor Alessandro Boccanelli is the current President of the Italian Society of Geriatric Cardiology (SICGE) and in 2002-2004 served as the President of ANMCO, the National Association of Hospital Cardiologists.

He has worked at the Cardiological Hospital of Ancona, Saint Camillus Hospital, and Saint John’s Hospital in Rome where he was the Director of the Department for Cardiovascular Diseases (1998-2013).

He is a Professor of Medicine at Uni Camillus, International University of Health and Medical Sciences, and a practicing cardiologist at Quisisana, a world class cardiac care and cardiological rehabilitation center.

In 2013, he founded the non profit association “Salute e Società” which is focused on improving the relationship between healthcare, welfare and society.

He is the author of over 300 scientific publications in national and international medical journals.

Scroll to read more
photo
Gualtiero Colombo MD PhD

Director, Functional Genomics Lab, Monzino Hospital

university
Biography

Dr. Colombo is the Head of the Unit of Immunology and Functional Genomics and Head of the Open Innovation Area at the Monzino IRCCS Cardiology Center, Milan.

He specializes in Allergology and Clinical Immunology and has a PhD in Biotechnology in the Medical Sciences.

He previously taught at the Schools of Specialization in Hygiene and Preventive Medicine, Infectious Diseases and Tropical Medicine and the School of Medicine at the University of Milan. Dr. Colombo has also carried out clinical and research activities at the Department of Internal Medicine of the University of Milan and the Policlinico Hospital in Milan.

His main areas of research focus on the genetics and genomics of atherosclerosis and cardiovascular disease, and the identification of new molecular biomarkers of cardiovascular diseases.

Dr. Colombo has been published in over 65 international scientific journals including Circulation Research, Arteriosclerosis Thrombosis and Vascular Biology, Bioinformatics, and the European Heart Journal.

Scroll to read more
photo
Giordano Bottà PhD CEO & Co-Founder

Giordano is a molecular biologist with a PhD in Public Health. During his career as a researcher he had the opportunity to work with some of the top genomics experts in the world at the University of Oxford publishing in the journal Nature. He wants to give people the opportunity to benefit from the scientific revolution happening in genomics by creating digital products that allow the extraordinary information carried in our DNA to be used effectively.

Field: Molecular Biology & Bioinformatics
photo
Paolo Di Domenico CTO, Head of Research and Development, Co-Founder

Paolo is a software engineer. He programmed his first software in Basic at the age of 5 with a Commodore 64. Since then he has gained experience in numerous programming languages and in designing complex cloud architecture. His goal is to develop algorithms and software that can translate the latest scientific findings in genomic prediction into clinical practice.

Field: Software Engineering & Data Mining
photo
George Busby PhD CSO, Head of Clinical Communication, Co-Founder

George is a statistical geneticist and science communicator. He has worked at the University of Oxford for more than 10 years and his scientific work has been published in Nature and Science, amongst other journals. He has always been fascinated by the potential of DNA to be used to reconstruct human evolutionary history by analyzing large genomic datasets with advanced statistical modeling. He now leads Allelica's scientific team, helping to bring polygenic risk scores to the market for the first time by showing their use in medical genetics.

Field: Molecular Biology & Bioinformatics
photo
Scott Kulm PhD

Scientist, Polygenic Risk Score Modelling

Field: Genomics & Bioinformatics
photo
Emma Perez

Genetic Counselor

Field: Clinical Genetics & Genetic Counselling
photo
Paolo Parisen Toldin PhD

Head of Genomic Information Technology

Field: Software and High Performance Computing
photo
Colleen Lyons

Business & Partnership Development

Field: Marketing & Science
photo
Deo Mujwara PhD

Health Economist

Field: Healthcare Policy & Research
photo
Jen Kintzle

Senior Product Specialist

Field: Bioinformatics & Clinical Genomics
photo
Alessandro Bolli PhD

Head of Data Science

Field: Data Analysis
photo
Samir Gahramanov

Software Engineer

Field: Software & Cloud-architecture